Mkt Cap$2.26T+1.98%
24h Vol$64.63B
BTC Dom55.6%
ETH Dom9.4%
F&G22Extreme Fear
BTC$62,652.00+2.12% ETH$1,757.50+3.22% USDT$0.9991+0.04% BNB$572.23+2.14% USDC$0.9999+0.01% XRP$1.15+4.93% SOL$83.72+3.90% TRX$0.3236+2.08% FIGR_HELOC$1.01-2.89% HYPE$71.78+7.98% DOGE$0.0777+4.32% RAIN$0.0155-0.35% USDS$0.9997+0.01% LEO$9.16+0.40% ZEC$463.61+8.37% XLM$0.208+5.11% BTC$62,652.00+2.12% ETH$1,757.50+3.22% USDT$0.9991+0.04% BNB$572.23+2.14% USDC$0.9999+0.01% XRP$1.15+4.93% SOL$83.72+3.90% TRX$0.3236+2.08% FIGR_HELOC$1.01-2.89% HYPE$71.78+7.98% DOGE$0.0777+4.32% RAIN$0.0155-0.35% USDS$0.9997+0.01% LEO$9.16+0.40% ZEC$463.61+8.37% XLM$0.208+5.11%
News

LEGN

Total Stories
2
Section
LEGN
Legend Biotech (LEGN) Shows Strong Q3 Performance Despite Revenue Shortfall
Earnings

Legend Biotech (LEGN) Shows Strong Q3 Performance Despite Revenue Shortfall

Legend Biotech posted Q3 2025 EPS of -$0.11 and revenue of $272.33 million, supported by strong demand for CARVYKTI®.

Tim FriesNov 12, 20253 min read